#1 out of 730869.7K est. views12.77%
health16h ago
FDA Approves Wegovy Weight Loss Pill From Novo Nordisk
Today.com and 16 more
- The FDA approval marks a milestone in broadening access to obesity pharmacotherapy by expanding delivery formats for semaglutide.
- In a clinical trial, participants who took oral Wegovy lost 13.6% of their total body weight on average over about 15 months, compared with a 2.2% loss if they took a placebo, That’s nearly the same as injectable Wegovy, with an average weight loss of about 15%.
- The Novo Nordisk obesity pill contains 25 milligrams of semaglutide, the same ingredient in injectables Wegovy and Ozempic and in Rybelsus.
Vote 36



:max_bytes(150000):strip_icc():focal(749x0:751x2)/Enrique-Iglesias-and-Anna-Kournikova-baby-122225-1650c77da70a4b238d66bf64d0ce0fcb.jpg)


:max_bytes(150000):strip_icc()/Anna-Enrique-Lead-aac598b684dd4e6fad71ff1105b3e0b3.jpg)













